Fierce Pharma

FDA's Makary pledges crackdown on mass marketing of 'illegal copycat drugs' in wake of Hims' Wegovy pill push

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...

U.S. signals crackdown on compounded weight-loss drugs; Hims shares tumble

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.
Becker's Hospital Review

War breaks out over GLP-1 pills

War breaks out over GLP-1 pills as Novo Nordisk takes legal action against Hims & Hers over compounded weight loss drugs.
Newsmax on MSN

FDA moves to restrict compounding GLP-1 ingredients

FDA Moves to Restrict Compounding GLP-1 Ingredients ...
24/7 Wall St.

FDA and HHS Hammer Hims & Hers In Compounded Drug Crackdown

Hims & Hers (NYSE:HIMS) shares are plunging 16% in after-hours trading following coordinated moves by two federal agencies ...
Health Affairs

Regulating Compounding Pharmacies

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...